WealthSource Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $644K | Sell |
22,386
-8,741
| -28% | -$264K | 0.04% | 268 |
|
|
2023
Q3 | $1.03M | Sell |
31,127
-4,184
| -12% | -$148K | 0.07% | 190 |
|
|
2023
Q2 | $1.3M | Buy |
35,311
+5,224
| +17% | +$203K | 0.09% | 164 |
|
|
2023
Q1 | $1.23M | Sell |
30,087
-4,141
| -12% | -$179K | 0.08% | 173 |
|
|
2022
Q4 | $1.75M | Sell |
34,228
-6,893
| -17% | -$330K | 0.12% | 130 |
|
|
2022
Q3 | $1.8M | Buy |
41,121
+4,716
| +13% | +$229K | 0.13% | 128 |
|
|
2022
Q2 | $1.91M | Sell |
36,405
-4,694
| -11% | -$239K | 0.14% | 121 |
|
|
2022
Q1 | $2.13M | Buy |
41,099
+1,312
| +3% | +$68.1K | 0.14% | 117 |
|
|
2021
Q4 | $2.35M | Sell |
39,787
-6,684
| -14% | -$331K | 0.19% | 90 |
|
|
2021
Q3 | $2M | Sell |
46,471
-4,295
| -8% | -$190K | 0.17% | 98 |
|
|
2021
Q2 | $1.99M | Buy |
50,766
+9,156
| +22% | +$356K | 0.18% | 92 |
|
|
2021
Q1 | $1.51M | Buy |
41,610
+6,338
| +18% | +$225K | 0.15% | 110 |
|
|
2020
Q4 | $1.3M | Sell |
35,272
-344
| -1% | -$12.6K | 0.15% | 92 |
|
|
2020
Q3 | $1.24M | Buy |
35,616
+5,803
| +19% | +$203K | 0.17% | 85 |
|
|
2020
Q2 | $925K | Sell |
29,813
-5,789
| -16% | -$197K | 0.13% | 99 |
|
|
2020
Q1 | $1.1M | Buy |
35,602
+8,620
| +32% | +$294K | 0.17% | 80 |
|
|
2019
Q4 | $1M | Buy |
26,982
+1,834
| +7% | +$65.3K | 0.13% | 141 |
|
|
2019
Q3 | $857K | Buy |
25,148
+1,314
| +6% | +$47.8K | 0.13% | 168 |
|
|
2019
Q2 | $980K | Buy |
23,834
+5,119
| +27% | +$203K | 0.15% | 141 |
|
|
2019
Q1 | $754K | Buy |
18,715
+1,288
| +7% | +$51.6K | 0.17% | 121 |
|
|
2018
Q4 | $722K | Sell |
17,427
-357
| -2% | -$14.8K | 0.21% | 108 |
|
|
2018
Q3 | $744K | Sell |
17,784
-1,059
| -6% | -$40.8K | 0.19% | 113 |
|
|
2018
Q2 | $649K | Sell |
18,843
-606
| -3% | -$20.7K | 0.18% | 122 |
|
|
2018
Q1 | $655K | Sell |
19,449
-4,364
| -18% | -$150K | 0.2% | 120 |
|
|
2017
Q4 | $818K | Sell |
23,813
-173
| -0.7% | -$5.9K | 0.25% | 92 |
|
|
2017
Q3 | $812K | Sell |
23,986
-391
| -2% | -$12.6K | 0.27% | 91 |
|
|
2017
Q2 | $777K | Sell |
24,377
-2,163
| -8% | -$68.2K | 0.26% | 92 |
|
|
2017
Q1 | $861K | Buy |
26,540
+4,508
| +20% | +$142K | 0.32% | 77 |
|
|
2016
Q4 | $679K | Sell |
22,032
-5,681
| -20% | -$173K | 0.29% | 78 |
|
|
2016
Q3 | $891K | Buy |
27,713
+11,551
| +71% | +$386K | 0.33% | 68 |
|
|
2016
Q2 | $540K | Sell |
16,162
-6,617
| -29% | -$211K | 0.2% | 102 |
|
|
2016
Q1 | $641K | Buy |
+22,779
| New | +$651K | 0.26% | 76 |
|
Other funds holding PFE
WealthSource Partners's PFE Position: Q4 2023 in Review
WealthSource Partners reduced its Pfizer (PFE) stake by 28% in Q4 2023, selling an estimated $264K and leaving 22,386 shares worth $644K. The position accounts for 0.04% of the portfolio, ranked #268.
WealthSource Partners first reported a position in PFE in Q1 2016 and has held it in 32 quarters since. The position peaked at $2.35M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- WealthSource Partners held 22,386 shares of Pfizer worth $644K as of Q4 2023.
- WealthSource Partners sold 8,741 Pfizer shares in Q4 2023, an estimated $264K.
- Pfizer made up 0.04% of WealthSource Partners's portfolio in Q4 2023, its #268 holding.
- WealthSource Partners first reported a position in Pfizer in Q1 2016 and has held it in 32 quarters since.
- WealthSource Partners's Pfizer position peaked at $2.35M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.